T1	Participants 219 287	men with urodynamically documented bladder outflow obstruction (BOO)
T2	Participants 297 403	One hundred twenty-one men with benign prostatic enlargement (BPE) and lower urinary tract symptoms (LUTS)
T3	Participants 1033 1110	54 patients who completed 24 months of treatment with finasteride is provided
